Alecensa
My Prescription
Payment
Select pharmacy
$21,101.17
Print or send this coupon to your phone
AlbertsonsPowered byAbout Alecensa
Drug Details
Alectinib, marketed as Alecensa, is a medication used to treat non-small cell lung cancer (NSCLC) in adults, specifically targeting cases that are positive for a change in the anaplastic lymphoma kinase (ALK) gene. It is particularly utilized for ALK-positive NSCLC that has metastasized, or spread to other parts of the body, and can also be used post-surgery for early-stage NSCLC. Alectinib is classified as a tyrosine kinase inhibitor and functions by inhibiting the ALK protein, thereby slowing or stopping the growth of cancer cells. This drug is administered orally twice daily. Patients may experience common side effects such as constipation, fatigue, and muscle pain.
Price history for Alecensa
240 Capsules, 150MG
Average retail price for Alecensa
Average SaveHealth price for Alecensa
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Alecensa dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 150MG | 240 Capsules | $21,101.17 | $87.92 |
Alecensa FAQs
Alecensa is not a traditional chemotherapy drug. It is a targeted therapy medication used to treat non-small cell lung cancer (NSCLC) that is ALK-positive. It works by inhibiting the activity of the anaplastic lymphoma kinase (ALK) protein, which can help slow or stop the growth of cancer cells.
The cost of ALECENSA in the United States can vary depending on factors such as the pharmacy, insurance coverage, and location. Without insurance, the price can be quite high, often several thousand dollars for a month's supply. It is advisable for individuals to check with their specific pharmacy and insurance provider for the most accurate and up-to-date pricing information. Additionally, there may be patient assistance programs available to help offset the cost.
Alecensa (alectinib) has been approved for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive, metastatic non-small cell lung cancer (NSCLC). This indication includes its use as a first-line treatment option.
Yes, alectinib is known to shrink tumors in patients with ALK-positive non-small cell lung cancer. It works by inhibiting the activity of the anaplastic lymphoma kinase (ALK) protein, which can help reduce tumor size and slow the progression of the disease.
The cost of alectinib in Canada can vary depending on factors such as the pharmacy, location, and whether the patient has insurance coverage. It is recommended to contact local pharmacies or healthcare providers for the most accurate and up-to-date pricing information. Additionally, patients may explore assistance programs that could help reduce the cost.